ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

No reported Common Stock figures are available to summarize.

Common Stock history

Currency unavailable · from the balance sheet

No Common Stock data reported for this period type.

Common Stock vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Common Stock for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WVEWave Life Sciences Ltd.Mar 2026$1.63B USD+37.9%+26.3%278.8%
SLNSilence Therapeutics plcMar 2026$10.29M USD+200.0%+24.1%8.9%
PRQRProQR Therapeutics N.V.Mar 2026€4.31M EUR-7.3%+8.5%4.4%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$28K USD+3.7%+1.2%0.0%
RNAAtrium Therapeutics, Inc.Mar 2026$16K USD——0.0%
STOKStoke Therapeutics, Inc.Mar 2026$6K USD+20.0%+7.7%0.0%
MGTXMeiraGTx Holdings plcMar 2026$3K USD+0.0%+14.5%0.0%
BNTCBenitec Biopharma Inc.Mar 2026$3K USD+50.0%—0.0%
PRMEPrime Medicine, Inc.Mar 2026$2K USD+0.0%+0.0%0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+11.9%+8.5%0.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.